Mesoblast Limited
Other OTCTotal Valuation
Mesoblast Limited carries a market capitalization of 2.46B, placing it among publicly traded companies globally. Its enterprise value stands at 2.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.46B |
| Enterprise Value | 2.06B |
Share Statistics
Mesoblast Limited currently has 1.29B shares outstanding.
| Shares Outstanding | 1.29B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Mesoblast Limited maintains a current ratio of 3.57, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.57 |
| Quick Ratio | 3.07 |
| Debt / Equity | 44.97 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Stock Price Statistics
Mesoblast Limited's stock has gained approximately 25.82781% over the past 52 weeks. The 50-day moving average sits at 1.73, while the 200-day moving average is 1.63.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25.82781% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 1.63 |
| Average Volume (20 Days) | N/A |
Cash Flow
| Operating Cash Flow | N/A |
| Capital Expenditures | -1.33M |
| Free Cash Flow | -1.33M |
| FCF Per Share | N/A |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.51 |
| FCF Yield | N/A |
Stock Splits
Mesoblast Limited's most recent stock split took place on December 11, 2023 with a 500:527 split ratio.
| Last Split Date | 12/11/2023 |
| Split Ratio | 500:527 |
Scores
Mesoblast Limited posts an Altman Z-Score of -1.50, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.50 |